TY - JOUR
T1 - Long-term outcomes after revision neural decompression and fusion for same-level recurrent lumbar stenosis
T2 - Defining the effectiveness of surgery
AU - Mendenhall, Stephen K.
AU - Parker, Scott L.
AU - Adogwa, Owoicho
AU - Shau, David N.
AU - Cheng, Joseph
AU - Aaronson, Oran
AU - Devin, Clinton J.
AU - McGirt, Matthew J.
N1 - Publisher Copyright:
Copyright © 2012 by Lippincott Williams & Wilkins.
PY - 2014/10/8
Y1 - 2014/10/8
N2 - Study Design: Single-cohort study of patients undergoing revision neural decompression and fusion for same-level recurrent lumbar stenosis.Objective: To assess the long-term outcomes of revision surgery using validated patient-reported outcomes measures.Summary of Background Data: Recurrent lumbar stenosis may occur after lumbar spine surgery, leading to significant discomfort and radicular pain. Although numerous studies have reported clinical outcomes after primary lumbar surgery, there remains a paucity of data on the outcomes after revision surgery for recurrent same-level stenosis.Methods: Fifty-three patients undergoing revision neural decompression and instrumented fusion for same-level recurrent stenosis-associated back and leg pain were included in this study. Baseline and 2-year visual analog scale for leg pain (LP-VAS), visual analog scale for low back pain (BP-VAS), Oswestry Disability Index (ODI), Zung self-reported depression score (ZDS), time to narcotic independence, time to return to work, health-state utility [EuroQol (EQ-5D)], and physical and mental quality of life [SF-12 physical and mental component scores (PCS and MCS)] were assessed.Conclusions: Our study suggests that revision neural decompression and instrumented fusion for recurrent same-level stenosis provides significant improvement in all patient-assessed outcome metrics and should be offered as a viable treatment option.Results: Mean ± SD duration of time between index surgery and revision surgery was 4.00 ± 4.19 years. A significant improvement from baseline was observed in BP-VAS (9.28 ± 1.01 vs. 5.00 ± 2.94, P = 0.001), LP-VAS (9.55 ± 0.93 vs. 3.45 ± 2.95, P = 0.001), and ODI (36.02 ± 6.01 vs. 21.75 ± 12.08, P = 0.001). Mean ± SD SF-12 PCS (7.17 ± 11.22, P = 0.001), SF-12 MCS (12.57 ± 13.03, P = 0.001), ZDS (12.37 ± 16.80, P = 0.001), and EQ-5D (0.42 ± 0.34, P = 0.001) were also significantly improved. The mean cumulative 2-year gain in health-utility state was 0.84 QALY. Median (interquartile range) duration of postoperative narcotic use was 6 (1.4-12.2) months and time of missed work was 6 (4.0-10.0) months.
AB - Study Design: Single-cohort study of patients undergoing revision neural decompression and fusion for same-level recurrent lumbar stenosis.Objective: To assess the long-term outcomes of revision surgery using validated patient-reported outcomes measures.Summary of Background Data: Recurrent lumbar stenosis may occur after lumbar spine surgery, leading to significant discomfort and radicular pain. Although numerous studies have reported clinical outcomes after primary lumbar surgery, there remains a paucity of data on the outcomes after revision surgery for recurrent same-level stenosis.Methods: Fifty-three patients undergoing revision neural decompression and instrumented fusion for same-level recurrent stenosis-associated back and leg pain were included in this study. Baseline and 2-year visual analog scale for leg pain (LP-VAS), visual analog scale for low back pain (BP-VAS), Oswestry Disability Index (ODI), Zung self-reported depression score (ZDS), time to narcotic independence, time to return to work, health-state utility [EuroQol (EQ-5D)], and physical and mental quality of life [SF-12 physical and mental component scores (PCS and MCS)] were assessed.Conclusions: Our study suggests that revision neural decompression and instrumented fusion for recurrent same-level stenosis provides significant improvement in all patient-assessed outcome metrics and should be offered as a viable treatment option.Results: Mean ± SD duration of time between index surgery and revision surgery was 4.00 ± 4.19 years. A significant improvement from baseline was observed in BP-VAS (9.28 ± 1.01 vs. 5.00 ± 2.94, P = 0.001), LP-VAS (9.55 ± 0.93 vs. 3.45 ± 2.95, P = 0.001), and ODI (36.02 ± 6.01 vs. 21.75 ± 12.08, P = 0.001). Mean ± SD SF-12 PCS (7.17 ± 11.22, P = 0.001), SF-12 MCS (12.57 ± 13.03, P = 0.001), ZDS (12.37 ± 16.80, P = 0.001), and EQ-5D (0.42 ± 0.34, P = 0.001) were also significantly improved. The mean cumulative 2-year gain in health-utility state was 0.84 QALY. Median (interquartile range) duration of postoperative narcotic use was 6 (1.4-12.2) months and time of missed work was 6 (4.0-10.0) months.
KW - Patient-reported outcomes
KW - Revision surgery
KW - Spine
KW - Stenosis
UR - http://www.scopus.com/inward/record.url?scp=84918498132&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84918498132&partnerID=8YFLogxK
U2 - 10.1097/BSD.0b013e31826105a5
DO - 10.1097/BSD.0b013e31826105a5
M3 - Article
C2 - 25247253
AN - SCOPUS:84918498132
SN - 1536-0652
VL - 27
SP - 353
EP - 357
JO - Journal of Spinal Disorders
JF - Journal of Spinal Disorders
IS - 7
ER -